Elixxer Ltd. Closes Private Placement

Rhea-AI Summary

On October 15, 2020, Elixxer announced the completion of a non-brokered private placement, issuing 26,666,666 units at CAD$0.015 each, totaling gross proceeds of $400,000. Each unit consists of one common share and one share purchase warrant, exercisable at CAD$0.05 for 60 months. The company intends to use the proceeds for general working capital and future investments. No fees were paid in connection with this offering, and the units are subject to a four-month hold period.

Positive

• Raised CAD$400,000 through private placement.
• No commissions or finder’s fees paid, increasing net capital.
• Warrants exercisable at a higher price of CAD$0.05 could generate additional funds.

Negative

• None.

MONTRÉAL, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company) is pleased to announce that it has closed its previously announced private placement with a strategic investor. Pursuant to the non-brokered private placement, the Company issued 26,666,666 units of the Company (the “Units”) at a price of CAD$0.015 per Unit for gross proceeds of $400,000. Each Unit consists of one common share of the Company and one common share purchase warrant. Each warrant is exercisable for a period of 60 months from the date of issuance at an exercise price of CAD$0.05 each.

No commission or finder’s fee has been paid in connection with the private placement. The Units have been issued pursuant to an exemption from the prospectus requirements of applicable securities legislation, and all securities are subject to a hold period of four months and one day from the date of issuance.  

The proceeds of the private placement will be used by the Company for general working capital purposes and to pursue future investments. It is anticipated that no payments from the proceeds will be made to related parties of the Company, and the proceeds will not primarily be used to pay management fees of for investor relations activities.

About Elixxer Ltd. (www.Elixxer.com)

Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).

Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.

For further information please contact: 

Mazen Haddad, CEO: mazen@elixxer.com 

Caution Regarding Press Releases

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Statements

This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in Elixxer’s most recent Management’s Discussion and Analysis filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.

FAQ

What is the recent private placement by Elixxer (ELIXF)?

Elixxer closed a non-brokered private placement, issuing 26,666,666 units at CAD$0.015 each for gross proceeds of $400,000.

What will Elixxer do with the proceeds from the private placement?

The proceeds will be used for general working capital and to pursue future investments.

What are the terms of the warrants issued by Elixxer?

Each warrant is exercisable at CAD$0.05 within a 60-month period from the date of issuance.

Are there any fees associated with Elixxer’s private placement?

No commissions or finder’s fees were paid in relation to the private placement.

Is there a hold period for the units issued by Elixxer?

Yes, the units are subject to a hold period of four months and one day from the date of issuance.